Sebastian Grosicki

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Chronic Lymphocytic Leukemia

Prognostic Factors

Placebo Controlled

Multiple Myeloma

Top Venues

Expert review of anticancer therapy

Future oncology (London, England)

Blood cancer journal

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Martyna Bednarczyk, Karolina Kociszewska, Olga Grosicka, Sebastian Grosicki
The role of autophagy in acute myeloid leukemia development. Expert review of anticancer therapy (2023)
Martyna Bednarczyk, Karolina Kociszewska, Olga Grosicka, Sebastian Grosicki
The role of autophagy in acute myeloid leukemia development. Expert review of anticancer therapy 23 (1) (2023)
Karolina Kociszewska, Martyna Bednarczyk, Sebastian Grosicki
Elranatamab: a new promising BispAb in multiple myeloma treatment. Expert review of anticancer therapy (2023)
Martyna Bednarczyk, Karolina Kociszewska, Olga Grosicka, Sebastian Grosicki
The role of autophagy in acute myeloid leukemia development. Expert review of anticancer therapy 23 (1) (2023)
Martyna Bednarczyk, Karolina Kociszewska, Olga Grosicka, Sebastian Grosicki
The role of autophagy in acute myeloid leukemia development. Expert review of anticancer therapy (2022)
Nicola Szeja, Sebastian Grosicki
Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment. Expert review of hematology 15 (1) (2022)
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit K Rampal, Srdan Verstovsek, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben A Mesa, Andrew T Kuykendall, Alessandro Maria Maria Vannucchi, Francesca Palandri, Sebastian Grosicki, Timothy Devos, Eric Jourdan, Marielle J Wondergem, Haifa Kathrin Al-Ali, Veronika Buxhofer-Ausch, Alberto Álvarez-Larrán, Andrea Patriarca, Marina Kremyanskaya, Adam J Mead, Sanjay Akhani, Yuri Sheikine, Gozde Colak, John O Mascarenhas
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. Future oncology (London, England) 18 (27) (2022)
Aleksander Salomon-Perzyński, Joanna Barankiewicz, Marcin M Machnicki, Irena Misiewicz-Krzeminska, Michał Pawlak, Sylwia Radomska, Agnieszka Krzywdzińska, Aleksandra Bluszcz, Piotr Stawiński, Malgorzata Rydzanicz, Natalia Jakacka, Iwona Solarska, Katarzyna Borg, Zofia Spyra-Górny, Tomasz Szpila, Bartosz Puła, Sebastian Grosicki, Stokłosa Tomasz, Ploski Rafal, Ewa Lech-Marańda, Jana Jakubikova, Krzysztof Jamroziak
Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing. Biomedicines 10 (7) (2022)
Sebastian Grosicki, Martyna Bednarczyk, Agnieszka Barchnicka, Olga Grosicka
Elotuzumab in the treatment of relapsed and refractory multiple myeloma. Future oncology (London, England) 17 (13) (2021)
Bożena Katarzyna Budziszewska, Aleksander Salomon-Perzyński, Katarzyna Pruszczyk, Joanna Barankiewicz, Agnieszka Pluta, Grzegorz Helbig, Anna Janowska, Marta Kuydowicz, Łukasz Bołkun, Jarosław Piszcz, Elżbieta Patkowska, Marzena Wątek, Piotr Małecki, Sylwia Kościołek-Zgódka, Edyta Cichocka, Grzegorz Charliński, Anna Irga-Staniukiewicz, Jan Maciej Zaucha, Agnieszka Piekarska, Tomasz Gromek, Marek Hus, Karol Wójcik, Małgorzata Raźny, Mariola Sędzimirska, Bartosz Puła, Sebastian Giebel, Sebastian Grosicki, Agnieszka Wierzbowska, Ewa Lech-Marańda
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG). Cancers 13 (16) (2021)
Marta Masternak, Bartosz Puła, Joanna Knap, Anna Waszczuk-Gajda, Joanna Drozd-Sokołowska, Kamil Wdowiak, Sebastian Grosicki, Izabela Kozłowska, Marta Kaźmierczak, Anna Łabędź, Łukasz Szukalski, Kamil Wiśniewski, Edyta Subocz, Janusz Hałka, Agnieszka Szymczyk, Marek Hus, Krzysztof Jamroziak, Krzysztof Giannopoulos
Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia. Cancer management and research 12 (2020)
Meletios- Athanasios Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Katja Weisel, Jesus San-Miguel, Ofer Shpilberg, Sebastian Grosicki, Ivan Špička, Adam Walter-Croneck, Hila Magen, Maria-Victoria Mateos-Manteca, Andrew Belch, Donna Reece, Meral Beksac, Andrew Spencer, Heather Oakervee, Robert Z Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Morio Matsumoto, Ka Lung Wu, Kenneth C Anderson, Ying-Ming Jou, Alex Ganetsky, Anil K Singhal, Paul G Richardson
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study. Blood cancer journal 10 (9) (2020)
Marinus van Oers, Lukas Smolej, Mario Petrini, Fritz Offner, Sebastian Grosicki, Mark-David Levin, Jaclyn Davis, Hiya Banerjee, Tommaso Stefanelli, Petra Hoever, Christian Geisler
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study. Blood cancer journal 9 (12) (2019)